Geometric Deep Learning for Multi-Target Drug Design and Polypharmacology
July 24, 2026
This review analyzes how geometric deep learning architectures, such as SE(3)-equivariant diffusion models, enable the design of ligands that satisfy the geometric constraints of multiple protein targets. It positions GDL as a solution to the computational bottlenecks in treating multifactorial diseases through polypharmacology.
HOW THIS AFFECTS YOU
●
researcherYou can leverage equivariant models to capture 3D structural interdependencies in molecular data.
●
healthThis changes how drug discovery approaches complex, multi-target diseases like cancer.